LMND

Lemonade Inc

Add to Watchlist

Advanced Chart

75.020

-0.11(-0.146%)1D

Line

Candle

YTD

High

75.040

Open

73.550

VWAP

72.60

Vol

4.26M

Mkt Cap

5.61B

Low

69.030

Amount

309.58M

EV/EBITDA(TTM)

Total Shares

70.50M

5.40B

EV/OCF(TTM)

P/S(TTM)

8.33

Lemonade, Inc. offers renters, homeowners, car, pet, and life insurance. The Company operates through the United States, Europe, including the United Kingdom, providing insurance products to customers through various sales channels. The Company's digital substrate enables it to integrate marketing and onboarding with underwriting and claims processing, collecting, and deploying data. Its technology includes Data Advantage, AI Maya, AI Jim, CX.AI, Forensic Graph, Blender, and Cooper. AI Maya, its onboarding and customer experience bot, uses natural language to guide customers in joining the Company. AI Jim, its claims bot, takes the first notice of loss from its customer without human intervention. It offers pet insurance that covers diagnostics, procedures, medication, accidents or illness. Even its basic pet insurance offering covers blood tests, urinalysis, lab work, and computed tomography scans.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q2

FY2026Q1

FY2025Q4

274.82M

+67.47%

-0.549

-8.57%

241.27M

+59.57%

-0.584

-32.06%

215.53M

+44.84%

-0.424

+1.02%

Estimates Revision

The market is revising Upward the revenue expectations for Lemonade, Inc. (LMND) for FY2025, with the revenue forecasts being adjusted by 0.53% over the past three months. During the same period, the stock price has changed by 43.25%.

Revenue Estimates for FY2025

Revise Upward

+0.53%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-3.65%

In Past 3 Month

Stock Price

Go Up

+43.25%

In Past 3 Month

9 Analyst Rating

-41.54% Downside

Wall Street analysts forecast LMND stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LMND is 43.86 USD with a low forecast of 33.00 USD and a high forecast of 60.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

4 Hold

4 Sell

Moderate Sell

-41.54% Downside

Current: 75.020

Low

33.00

Averages

43.86

High

60.00

-41.54% Downside

Current: 75.020

Low

33.00

Averages

43.86

High

60.00

Piper Sandler

Neutral

maintain

$55 -> $60

2025-09-17

Reason

Piper Sandler

Price Target

$55 -> $60

2025-09-17

maintain

Neutral

Reason

Piper Sandler raised the firm's price target on Lemonade to $60 from $55 and keeps a Neutral rating on the shares. The firm cites increased interest in AI and this is the name to play for the long-term for that. Piper also points out that this is a growth name, which suggests the potential for a true network effect, and notes profitability has improved. On the flip side, the firm acknowledges there has been increased risk exposure, and there is a reliance on direct-to-consumer in a country slow to adopt DTC for insurance purchasing needs historically.

BMO Capital

Jack Matten

Underperform

maintain

$23 -> $42

2025-08-18

Reason

BMO Capital

Jack Matten

Price Target

$23 -> $42

2025-08-18

maintain

Underperform

Reason

BMO Capital analyst Jack Matten raised the firm's price target on Lemonade to $42 from $23 and keeps an Underperform rating on the shares. The firm believes that Lemonade's growth will require less capital vs. personal insurance peers, given its less restricted from a rating agency perspective, the analyst tells investors in a research note. BMO adds that its base-case continues to be that Lemonade will not need a capital raise, though the stock price now reflects a best-case scenario in which Lemonade can scale profitably in highly-competitive auto insurance.

Morgan Stanley

Underweight

maintain

$40 -> $43

2025-08-18

Reason

Morgan Stanley

Price Target

$40 -> $43

2025-08-18

maintain

Underweight

Reason

Morgan Stanley raised the firm's price target on Lemonade to $43 from $40 and keeps an Underweight rating on the shares. The firm is updating its price targets on Property & Casualty Insurance stocks under its coverage following Q2 results, the analyst tells investors. Themes across the P&C insurance sector include: increased competition in the personal auto insurance market; cautious optimism over growth opportunities in commercial lines; softened reinsurance pricing through mid-year renewals; and in-line Q2 results delivered by brokers, the analyst tells investors.

Piper Sandler

John Barnidge

Neutral

initiated

$55

2025-08-14

Reason

Piper Sandler

John Barnidge

Price Target

$55

2025-08-14

initiated

Neutral

Reason

Piper Sandler analyst John Barnidge assumed coverage of Lemonade with a Neutral rating and $55 price target. The firm notes the company has seen shares meaningfully re-rate this year as volatility of the business has improved, total customer growth has persisted and premium per customer continues to grow. That said, Piper believes the valuation is reflective of that meaningful improvement in the leading direct-to-consumer provider of personal lines products in the U.S. While the company was often 1st brought to the public's conscience due to its home insurance product, the pet insurance business has seen rapid growth in recent years, it adds.

Cantor Fitzgerald

Ryan Tunis

Overweight

initiated

$60

2025-08-12

Reason

Cantor Fitzgerald

Ryan Tunis

Price Target

$60

2025-08-12

initiated

Overweight

Reason

Cantor Fitzgerald analyst Ryan Tunis initiated coverage of Lemonade with an Overweight rating and $60 price target.

Oppenheimer

maintain

2025-08-05

Reason

Oppenheimer

Price Target

2025-08-05

maintain

Reason

Oppenheimer says Lemonade's investment story is "largely unchanged" following the Q2 report despite the company's move to cede less premium to reinsurance partners. Lemonade is seeing strong growth from car and Europe and is progressing toward profitability, the analyst tells investors in a research note. The firm reduced EBITDA estimates but says the company's loss ratios continue to improve. Opco keeps a Perform rating on the shares. The stock in afternoon trading is up 28%, or $10.52, to $47.51.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Lemonade Inc (LMND.N) is -37.92, compared to its 5-year average forward P/E of -11.49. For a more detailed relative valuation and DCF analysis to assess Lemonade Inc 's fair value, click here.

Forward PE
Forward EV/EBITDA
Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-11.49

Current PE

-37.92

Overvalued PE

-2.16

Undervalued PE

-20.82

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-13.53

Current EV/EBITDA

-78.82

Overvalued EV/EBITDA

-2.00

Undervalued EV/EBITDA

-25.06

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

12.21

Current PS

75.02

Overvalued PS

29.96

Undervalued PS

-5.54